Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 194

Sort by

Sort Order Select

Journal Articles

Azacitidine (AZA) with Nivolumab (Nivo), and AZA with Nivo + Ipilimumab (Ipi) in Relapsed/Refractory Acute Myeloid Leukemia: A Non-Randomized, Prospective, Phase 2 Study

Blood (2019) 134 (Supplement_1): 830.

https://doi.org/10.1182/blood-2019-131494

Published: 2019

Journal Articles

Kinetics of Immune Reconstitution after CD19 CAR-T Cell Therapy in ALL Patients

Ying Wang, Jiang Cao, MD, Yan Zhiling, MD, Jianlin Qiao, PhD, Deipeng Li, MD, Zhenyu Li, MD, Kailin Xu, MD

Blood (2019) 134 (Supplement_1): 1301.

https://doi.org/10.1182/blood-2019-127808

Published: 2019

Journal Articles

Haplo-Cord Transplantation with Anti-Thymocyte Globulin: Comparative Clinical Outcomes with or without Routine G-CSF Administration

Nina Orfali, MB,PhD, Alexandra Gomez-Arteaga, MD, Danielle Guarneri, BS, CCRP, Jingmei Hsu, MD, Adrienne A. Phillips, MD MPH, Usama Gergis, MD MBA, Tsiporah B. Shore, MD, Sebastian A. Mayer, MD, Koen Van Besien, MD PhD

Blood (2019) 134 (Supplement_1): 2000.

https://doi.org/10.1182/blood-2019-129452

Published: 2019

Journal Articles

TCR Repertoire Clonality Analysis and Transcriptome Analyses of Immune Infiltrates in Patients with Langerhans Cell Histiocytosis Can Define Prognostic Biomarkers for Future Therapeutic Development

Rikhia Chakraborty, PhD, Jessica Velasquez, Amel Sengal, BS, Ankita Das, Vasumathi Kode, Nitin Mandloi, Miriam Merad, MD, Carl E. Allen, MD PhD

Blood (2019) 134 (Supplement_1): 3601.

https://doi.org/10.1182/blood-2019-129013

Published: 2019

Journal Articles

Composition of Immune Subpopulations Influence Multiple Myeloma Disease Progression

Rupal Ramakrishnan, Alexandra Achille, Tuan Nyugen, Ian Taylor, BS, Gabriel De Avila, BS, Raghunandanreddy Alugubelli, MS, Mark B. Meads, PhD, Ariosto Siqueira Silva, PhD, Kenneth H. Shain, MD PhD, Jason B. Brayer, PhDMD

Blood (2019) 134 (Supplement_1): 4392.

https://doi.org/10.1182/blood-2019-131966

Published: 2019

Journal Articles

Increased Incidence of Viral Reactivation after T Cell Replete Haploidentical Stem Cell Transplantation in Association with Delayed Immune Reconstitution

Ioannis Tsonis, MD, Dimitrios Karakasis, MD, Maria Bouzani, MD, Chara Giatra, MD, Zois Mellios, MD, Georgia Tounta, MD, Tatiana Tzenou, MD, Dimitra Oikonomopoulou, MD, Eirini Grispou, Maria Katsareli, Maria-Eleni Karatza, Kimon Fountoulis, MD, Themistoklis Karmiris, MD, Stavros Gigantes, MD, Ioannis Baltadakis, MD

Blood (2019) 134 (Supplement_1): 4511.

https://doi.org/10.1182/blood-2019-131127

Published: 2019

Journal Articles

The Immune Micro-Environment in Diffuse Large B Cell Lymphoma Is Characterised By an Immunosuppressive Shift in T Cell Subsets

Edward Truelove, MBBS, BSc, MRCP, FRCPath, Frances Seymour, MRCP, BSc, MBBS, Joseph G Taylor, MBBS, BSc, Mariarita Calaminici, Andrew James Clear, BSc, John G. Gribben, MD DSc

Blood (2019) 134 (Supplement_1): 5240.

https://doi.org/10.1182/blood-2019-130712

Published: 2019

Journal Articles

CD4 Lymphocytes and T Regulatory Cells Show Distinct Phenotypes in Follicular Lymphoma and Classical Hodgkin Lymphoma Which May Account for Differences in Responses to Checkpoint Therapy

Sary El Daker, PhD, Qi Gao, MLS, Mikhail Roshal, MD PhD, Ahmet Dogan, MD PhD

Blood (2019) 134 (Supplement_1): 1513.

https://doi.org/10.1182/blood-2019-130346

Published: 2019

Journal Articles

Cytotoxic CD4+ Cells in Chronic Lymphocytic Leukaemia: An Extended Immunophenotypic Analysis Examining Their Association with Cytomegalovirus Serostatus and Similarities with Cytotoxic CD8+ Cells

Maria A V Marzolini, Ayse Akarca, Karen Teng, Teresa Marafioti, MD, Satyen H Gohil, Amit C Nathwani, MD PhD, Evan Newell, PhD, Sergio A Quezada, Karl S Peggs

Blood (2018) 132 (Supplement 1): 3130.

https://doi.org/10.1182/blood-2018-99-116798

Published: 2018

Journal Articles

Modeling Sézary Syndrome for Immunophenotyping and Anti-Tumor Effect of Ucart and Long-Acting Interleukin-7 Combination Therapy

Karl W. Staser, MD PhD, Matthew L. Cooper, PhD, Jaebok Choi, PhD, Anand Chukka, Kidist Ashami, BA, Jessica Niswonger, Jaehan Park, Byung Ha Lee, PhD, Shunqiang Li, PhD, Amanda F Cashen, MD, Amy Musiek, MD, John F. DiPersio, MD PhD

Blood (2018) 132 (Supplement 1): 340.

https://doi.org/10.1182/blood-2018-99-119375

Published: 2018

Journal Articles

The Treg/Th17 Axis Is Skewed in Classical Hodgkin Lymphoma By PDL1+Ve but Not PDL1-Ve Lymphoma Cells and By Lymphoma MHC Class 2 Expression.

Joseph G Taylor, MBBS, BSc, Andrew James Clear, BSc, Janet Matthews, Mariarita Calaminici, John G. Gribben

Blood (2018) 132 (Supplement 1): 4124.

https://doi.org/10.1182/blood-2018-99-119126

Published: 2018

Journal Articles

First-in-Human Clinical Trial to Determine the Safety and Potency of Inducible T Regulatory Cells after Allogeneic Hematopoietic Cell Transplantation

Margaret L. MacMillan, MD, Keli Lee Hippen, PhD, David H. McKenna, MD, Todd E. DeFor, MS, Erica D. Warlick, MD, Claudio G Brunstein, MD PhD, Jeffrey S. Miller, MD, Daniel J. Weisdorf, MD, Bruce R. Blazar, MD, John E. Wagner, MD

Blood (2018) 132 (Supplement 1): 2112.

https://doi.org/10.1182/blood-2018-99-113100

Published: 2018

Journal Articles

DA-EPOCH Was Not Better Than CHOP for Acquired Immunodeficiency Syndrome-Related Diffuse Large B Cell Lymphoma Patients Treated in a South Brazilian University Hospital

Carolina F Gomes, MD, Tito Vanelli, MD, Gueverson Rocha, Biomedical, Jeziel Basso, MD, Juliana Collman Silva, MD, Nicole Teixeira Carvalho, MD, Tatiana de Campos, MD, Harold Fabian Ibanez Torres, MD, Lucia Silla, MD PhD, Paz Aparecida Alessandra, MD, Laura Maria Fogliatto, MD

Blood (2018) 132 (Supplement 1): 5414.

https://doi.org/10.1182/blood-2018-99-117862

Published: 2018

Journal Articles

CD4+ T-Cell Lymphopenia in Frequent Platelet Donors Who Have Ceased Platelet Donation for at Least 1 Year

Mahboubeh Rahmani, MD, Brooke M Fortin, BA, BS, Nancy Berliner, MD, Nicolas C Issa, MD, Donna S Neuberg, ScD, Richard M Kaufman, MD, John M Gansner, MD PhD

Blood (2018) 132 (Supplement 1): 2550.

https://doi.org/10.1182/blood-2018-99-118967

Published: 2018

Journal Articles

Peritoneal Cavity Cells Ameliorate Graft-Versus-Host Disease of Mice after MHC Mismatched Bone Marrow Transplantation

Zhigang Liu, MD, Wanhua Zhang, MD, Xinchuan Chen, MD, Chuan He, MD, Jie Ji, MD, Ting Liu, MD

Blood (2018) 132 (Supplement 1): 5675.

https://doi.org/10.1182/blood-2018-99-114510

Published: 2018

Journal Articles

Somatic Mutations in CD8+ T Cells in Patients with Chronic Immune Thrombocytopenia Are Associated with Increased Clonality and Cytotoxic Phenotype of CD8+ T Cells

Hanna Rajala, MD PhD, Paula Savola, MD, Sofie Lundgren, BMed, Samuli Eldfors, PhD, Tiina Kelkka, PhD, Freja Ebeling, MD PhD, Satu Mustjoki, MDPhD

Blood (2018) 132 (Supplement 1): 131.

https://doi.org/10.1182/blood-2018-99-113373

Published: 2018

Journal Articles

Mechanisms of CD4 T Cell Tumor Immunity in a Preclinical Model of Multiple Myeloma

Selma Bekri, PhD, Reunet Rodney-Sandy, BS, Diana Gruenstein, BS, Bjarne Bogen, MD PhD, Daniel Levey, PhD, Hearn Jay Cho, MD

Blood (2018) 132 (Supplement 1): 1947.

https://doi.org/10.1182/blood-2018-99-117129

Published: 2018

Journal Articles

Kinetics of T-Cell Subset Reconstitution Following Bendamustine-Containing Therapy for Low-Grade Lymphoproliferative Disease; A Population Based Analysis

Sarah Hartley, MBBS, MRCP, Amy Beech, Catherine Griffiths, Faith Richardson, Helen Knight, Andrew K. McMillan, FRCP, Mark Bishton, Chris P Fox

Blood (2017) 130 (Supplement 1): 3586.

https://doi.org/10.1182/blood.V130.Suppl_1.3586.3586

Published: 2017

Journal Articles

Targeting the HTLV-I-Regulated BATF3/IRF4 Transcriptional Network in Adult T-Cell Leukemia/Lymphoma

Blood (2017) 130 (Supplement 1): 731.

https://doi.org/10.1182/blood.V130.Suppl_1.731.731

Published: 2017

Journal Articles

Ebv-Mir-BART11-3p, Ebv-Mir-BART9 and Ebv-Mir-BART10 Are Present in the Plasma of HIV-Infected Subjects with Lymphoma and Are Potential Lymphoma Biomarkers

Josep Muncunill, MSc, Maria Joao Baptista, PhD PharmD, Agueda Hernandez-Rodriguez, PhD, Judith Dalmau, PhD, Gustavo Tapia, MD PhD, Olga Garcia, Miriam Moreno, MD, Juan-Manuel Sancho, MD PhD, Javier Martinez-Picado, PhD, Josep-Maria Ribera, MD, Evarist Feliu, MD PhD, Jose-Luis Mate, MD PhD, Jose Tomas Navarro, MD PhD

Blood (2017) 130 (Supplement 1): 4004.

https://doi.org/10.1182/blood.V130.Suppl_1.4004.4004

Published: 2017

NARROW

Azacitidine (AZA) with Nivolumab (Nivo), and AZA with Nivo + Ipilimumab (Ipi) in Relapsed/Refractory Acute Myeloid Leukemia: A Non-Randomized, Prospective, Phase 2 Study

Kinetics of Immune Reconstitution after CD19 CAR-T Cell Therapy in ALL Patients

Haplo-Cord Transplantation with Anti-Thymocyte Globulin: Comparative Clinical Outcomes with or without Routine G-CSF Administration

TCR Repertoire Clonality Analysis and Transcriptome Analyses of Immune Infiltrates in Patients with Langerhans Cell Histiocytosis Can Define Prognostic Biomarkers for Future Therapeutic Development

Composition of Immune Subpopulations Influence Multiple Myeloma Disease Progression

Increased Incidence of Viral Reactivation after T Cell Replete Haploidentical Stem Cell Transplantation in Association with Delayed Immune Reconstitution

The Immune Micro-Environment in Diffuse Large B Cell Lymphoma Is Characterised By an Immunosuppressive Shift in T Cell Subsets

CD4 Lymphocytes and T Regulatory Cells Show Distinct Phenotypes in Follicular Lymphoma and Classical Hodgkin Lymphoma Which May Account for Differences in Responses to Checkpoint Therapy

Cytotoxic CD4+ Cells in Chronic Lymphocytic Leukaemia: An Extended Immunophenotypic Analysis Examining Their Association with Cytomegalovirus Serostatus and Similarities with Cytotoxic CD8+ Cells

Modeling Sézary Syndrome for Immunophenotyping and Anti-Tumor Effect of Ucart and Long-Acting Interleukin-7 Combination Therapy

The Treg/Th17 Axis Is Skewed in Classical Hodgkin Lymphoma By PDL1+Ve but Not PDL1-Ve Lymphoma Cells and By Lymphoma MHC Class 2 Expression.

First-in-Human Clinical Trial to Determine the Safety and Potency of Inducible T Regulatory Cells after Allogeneic Hematopoietic Cell Transplantation

DA-EPOCH Was Not Better Than CHOP for Acquired Immunodeficiency Syndrome-Related Diffuse Large B Cell Lymphoma Patients Treated in a South Brazilian University Hospital

CD4+ T-Cell Lymphopenia in Frequent Platelet Donors Who Have Ceased Platelet Donation for at Least 1 Year

Peritoneal Cavity Cells Ameliorate Graft-Versus-Host Disease of Mice after MHC Mismatched Bone Marrow Transplantation

Somatic Mutations in CD8+ T Cells in Patients with Chronic Immune Thrombocytopenia Are Associated with Increased Clonality and Cytotoxic Phenotype of CD8+ T Cells

Mechanisms of CD4 T Cell Tumor Immunity in a Preclinical Model of Multiple Myeloma

Kinetics of T-Cell Subset Reconstitution Following Bendamustine-Containing Therapy for Low-Grade Lymphoproliferative Disease; A Population Based Analysis

Targeting the HTLV-I-Regulated BATF3/IRF4 Transcriptional Network in Adult T-Cell Leukemia/Lymphoma

Ebv-Mir-BART11-3p, Ebv-Mir-BART9 and Ebv-Mir-BART10 Are Present in the Plasma of HIV-Infected Subjects with Lymphoma and Are Potential Lymphoma Biomarkers

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only